Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.528 AUD | +0.49% | +4.98% | +17.50% |
04-30 | Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 | MT |
04-12 | RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 | MT |
Business Summary
Number of employees: 867
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Fertility Services
100.0
%
| 192 | 100.0 % | 214 | 100.0 % | +11.07% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Australia
94.0
%
| 182 | 94.7 % | 201 | 94.0 % | +10.28% |
International
6.0
%
| 10 | 5.3 % | 13 | 6.0 % | +25.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Knaap
CEO | Chief Executive Officer | - | 30/08/15 |
Malik Jainudeen
DFI | Director of Finance/CFO | - | 31/03/14 |
Thierry Panthier
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/19 |
Hamish Hamilton
COO | Chief Operating Officer | - | 31/12/04 |
Luk Rombauts
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/98 |
Chief Tech/Sci/R&D Officer | - | - | |
Michelle Lane
CTO | Chief Tech/Sci/R&D Officer | - | - |
Fiona Allen
SAM | Sales & Marketing | - | 30/06/19 |
Corporate Officer/Principal | - | 28/02/17 | |
Peggy North
HRO | Human Resources Officer | - | 28/02/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Broekhuizen
BRD | Director/Board Member | 58 | 03/06/14 |
Richard Davis
CHM | Chairman | 68 | 03/06/14 |
Richard Henshaw
BRD | Director/Board Member | - | - |
Josef Czyzewski
BRD | Director/Board Member | - | 03/06/14 |
Michael Knaap
CEO | Chief Executive Officer | - | 30/08/15 |
Zita Peach
BRD | Director/Board Member | 60 | 11/10/16 |
Catherine West
BRD | Director/Board Member | - | 07/09/20 |
Director/Board Member | - | 02-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 389,634,840 | 361,268,143 ( 92.72 %) | 0 | 92.72 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
MEMPHASYS 0.31% | 4,175,184 | 0.31% | 27,222 $ |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.50% | 386M | |
+16.17% | 81.21B | |
-29.41% | 70.26B | |
+10.99% | 29.62B | |
-11.35% | 16.95B | |
+0.21% | 16.91B | |
-0.68% | 15.07B | |
-1.40% | 12.52B | |
+3.44% | 12.1B | |
+31.43% | 12B |
- Stock Market
- Equities
- MVF Stock
- Company Monash IVF Group Limited